Heska’s Bob Grieve leads his pack to profitability

LOVELAND – Heska might not be the lead dog in its industry, but the veterinary products company has caught the scent of profitability and appears to be pulling up to the pack.

The Loveland-based animal-health-care firm has navigated the rocky road of drug development – where research costs are high and profits often far on the horizon – and is finally realizing the rewards of many years of difficult decisions.

In 1998, Heska lost $44.2 million – the most it’s lost as a publicly traded company. Prior to its initial public offering, the company had dug itself into a $38.4 million hole.…